Continuing Education Activity

Wernicke encephalopathy is an acute, time-sensitive neurologic disorder caused by thiamine deficiency that requires prompt recognition and treatment to prevent irreversible neurologic damage. The condition is often underdiagnosed because the classic triad of mental status changes, ataxia, and ophthalmoplegia is present in only a minority of patients. Risk factors extend beyond chronic alcohol use to include bariatric surgery, hyperemesis gravidarum, malignancy, dialysis, and critical illness. Bedside diagnostic frameworks, such as the Caine criteria, support early clinical recognition, while magnetic resonance imaging can provide supportive evidence. Negative imaging should not delay the initiation of treatment. Prompt administration of parenteral thiamine is preferred over oral supplementation during the acute phase to rapidly restore thiamine levels and prevent progression to Korsakoff syndrome or other severe neurologic sequelae. Early identification and treatment are critical to improving neurologic outcomes and reducing morbidity.

Participants in this course enhance their competence in recognizing Wernicke encephalopathy across diverse clinical settings, applying practical risk assessments, and implementing guideline-directed parenteral thiamine regimens. Clinicians gain skills in interpreting diagnostic frameworks and integrating supportive imaging findings without delaying therapy. The course emphasizes collaboration with an interprofessional team, including nurses, pharmacists, dietitians, and allied health professionals, to optimize thiamine administration, monitor for complications, and ensure continuity of care. Clinicians strengthen their ability to coordinate care, apply evidence-based interventions, and improve patient safety, functional recovery, and overall outcomes in individuals affected by Wernicke encephalopathy.

Objectives:

• Identify patients at high risk for Wernicke encephalopathy using clinical risk states and the Caine criteria.
• Interpret magnetic resonance imaging patterns that support Wernicke encephalopathy and proceed with care when imaging is nondiagnostic.
• Implement guideline-aligned parenteral thiamine dosing with timely magnesium replacement and safe sequencing with dextrose in suspected Wernicke encephalopathy.
• Coordinate interprofessional pathways to improve prophylaxis, screening, and early treatment for high-risk individuals.

Introduction

Wernicke encephalopathy is an acute neurological condition classically characterized by a clinical triad of ophthalmoparesis, often with nystagmus, gait instability with ataxia, and mental status change. This is a life-threatening illness caused by thiamine deficiency, which primarily affects the peripheral and central nervous systems. This disorder should be differentiated from Korsakoff syndrome, which is preventable and is usually suspected as a consequence of at least one episode of Wernicke’s encephalopathy. Korsakoff syndrome is a neuropsychiatric disorder associated with memory disturbances in which there are significant deficits in anterograde and retrograde memory.

Immediate memory is maintained, but short-term memory is diminished with intact sensorium. The disorder is associated with patients fabricating stories while in a state of clear consciousness. Confabulations can be spontaneous or provoked, with provoked confabulation commonly seen in chronic Korsakoff syndrome and spontaneous confabulation usually noted in the acute Wernicke state. Although most commonly associated with patients with alcohol use disorder, multiple other conditions can lead to thiamine deficiency and the development of Wernicke encephalopathy.[1][2][3]

Etiology

Thiamine deficiency is characteristically associated with severe alcohol use disorder. Although Wernicke encephalopathy primarily affects those who have a thiamine deficiency due to chronic alcoholism, various other causes include severe malnutrition, hyperemesis gravidarum, prolonged parenteral nutrition, malignancies in those on chemotherapy, immunodeficiency syndromes, liver disease, hyperthyroidism, and severe anorexia nervosa. Thiamine metabolism dysfunction syndrome-2 is a genetic condition resulting from a mutation in the thiamine transporter. Chronic alcohol consumption may lead to thiamine deficiency due to inadequate dietary intake and intestinal absorption, reduced hepatic storage, and other nutritional deficiencies, including magnesium deficiency, which is required for thiamine utilization within cells.[2][3][4][2][5]

Within 2 weeks of limited thiamine intake, thiamine reserves will likely be depleted, with further deficiency leading to a drop in blood thiamine levels and the development of Wernicke encephalopathy. A common inciting event for Wernicke encephalopathy is acute infection. Another trigger is prolonged carbohydrate or glucose loading in the presence of thiamine deficiency. In general, patients receiving glucose should also be administered thiamine concurrently or immediately before glucose administration. 

Epidemiology

Prevalence data on Wernicke encephalopathy come mainly from autopsy studies, with rates ranging between 1% and 3%. Autopsy series consistently show that Wernicke encephalopathy is far more common than clinical diagnoses suggest. Only about 20% of cases are recognized before death, and just 16% in nonalcoholic Wernicke encephalopathy. In children, 58% of cases were missed.[6]

The over-reliance on the “classic triad” and not considering patients without alcohol use disorder leads to missed diagnosis. Only about 16% present with all 3 features (encephalopathy, ophthalmoplegia, and ataxia), and approximately 19% may have none of the classic symptoms at initial evaluation, underscoring the need for a high index of suspicion.[7] The incidence of Wernicke encephalopathy is believed to be higher in developing countries due to vitamin deficiencies and malnutrition. The female-to-male ratio for Wernicke encephalopathy is 1:1.7, and no studies' results have shown that any particular race is predisposed to Wernicke encephalopathy.[8][6] 

For those who survive, 80% will go on to develop Korsakoff syndrome, which is characterized by severe memory defects. The mortality rate is estimated at 17%.[6] In addition to those with alcohol use disorder and malnutrition, other populations that are at an increased risk of Wernicke encephalopathy include those who rely on a diet based mainly on polished rice, those with gastrointestinal surgical procedures leading to malnutrition, patients with cancer and undergoing chemotherapy, and those with chronic vomiting, such as with anorexia nervosa and hyperemesis gravidarum. 

Pathophysiology

Thiamine, also known as Vitamin B1, is one of the first B vitamins to be discovered (see Table. The Importance of Dietary Thiamine). This vitamin is a coenzyme essential for complex metabolic pathways and plays a central role in cerebral metabolism. Vitamin B1 also acts as a cofactor for several enzymes in the Krebs cycle and the pentose phosphate pathway, including alpha-keto-glutamic acid oxidation and pyruvate decarboxylation. Thiamine-dependent enzymes function as a connection between the glycolytic and citric acid cycles.

Thiamine deficiency leads to decreased levels of alpha-ketoglutarate, acetate, and citrate, and to accumulation of lactate and pyruvate. Reduced nicotinamide adenine dinucleotide phosphate formation impairs antioxidant defenses, thereby increasing oxidative stress. Energy failure disrupts the blood–brain barrier, causing cytotoxic and vasogenic edema. Astrocytic glutamate uptake falters, leading to excitotoxic neuronal damage, while microglial activation and inflammatory signaling further propagate injury. 

These changes disrupt both neuronal and astrocytic function and particularly affect brain regions with high metabolic demand, such as the mammillary bodies, medial thalami, and periaqueductal gray matter.[9] Neuronal death in the mammillary bodies and thalamus was implicated in multiple cases of Wernicke encephalopathy studied. Studies using computed tomography (CT) and magnetic resonance imaging (MRI) in patients with Wernicke encephalopathy have revealed thalamic lesions, dilated ventricles, and mammillary body volume loss. The lesions are usually symmetrical in the midbrain, hypothalamus, and cerebellum.[10][11]

 Table. The Importance of Dietary Thiamine 

Table

Thiamine Role

ATP, adenosine triphosphate; NADPH, nicotinamide adenine dinucleotide phosphate; SLC19A2, solute carrier family 19 member 2; SLC19A3, solute carrier family 19 member 3; TDP, thiamine diphosphate

Histopathology

Symmetrical, greyish discoloration, fresh pinpoint hemorrhages, and congestion are seen in 50% of patients and are located in the periaqueductal grey matter, mamillary bodies, and medial thalamus. In 100% of patients, these changes affect specific areas, including the medial dorsal thalamic nucleus bilaterally. Rapid thiamine deficiency will show symmetrical small new hemorrhages in the brainstem and thalamus, with spongiosis between the hemorrhages, without interstitial infiltration of macrophages and without capillary proliferation. Swelling of astrocytes, minimal neuronal loss, decreased myelinated fibers, activated microglia, reactive astrogliosis, and prominent vessels are observed in chronic lesions.[6]

History and Physical

Wernicke encephalopathy should be suspected in any patient with chronic alcohol abuse or any form of malnutrition and any of the following: acute altered mental status, ophthalmoplegia, ataxic gait, delirium, and hypotension. The classic triad of Wernicke encephalopathy is altered mental status, ataxic gait, and ophthalmoplegia. The diagnosis is based on clinical presentation, and a definitive diagnosis is challenging because the clinical triad may be absent in up to 90% of patients. The most common symptom of Wernicke encephalopathy is mental status change, occurring in 34% to 82% of patients. Symptoms include confusion, drowsiness, apathy, cognitive impairment, spatial disorientation, dizziness, memory disturbance, and inability to concentrate. [3]

The hallmark sign of Wernicke encephalopathy is ocular abnormalities, particularly nystagmus, which occur in approximately 29% of patients.[6] Other oculomotor manifestations include involvement of the oculomotor, abducens, and vestibular nuclei, resulting in conjugate gaze palsies. Additional findings include pupillary sluggishness, ptosis, and anisocoria. Gait ataxia is also a significant finding, with patients presenting with a broad-based gait. Additionally, gait may deteriorate, and in many cases, patients are unable to walk. Twenty-three percent of patients experience a loss of equilibrium, with gait changes and trunk ataxia.

Physical examination should include a comprehensive neurological examination, including cerebellar testing. Disorientation and altered sensorium characterize encephalopathy. Some patients can present with hyperactive delirium secondary to possible alcohol withdrawal symptoms alongside Wernicke encephalopathy. Less than 5% of patients with Wernicke encephalopathy can present with a severely depressed level of consciousness that will eventually lead to coma and death. Some other warning signs could include hyperthermia and hypotension. The patient could also present with peripheral neuropathy, which commonly includes the lower extremity, and an examination would reveal distal sensory loss. Rarely, Wernicke encephalopathy can manifest with seizures. 

Wernicke encephalopathy should be considered in any patient with long-term malnutrition and episodes of confusion and altered mental status. Over the past few decades, bariatric surgery has been associated with Wernicke encephalopathy and malnutrition, primarily because postoperative food intake is limited and thiamine stores are rapidly depleted. Due to diagnostic challenges and the lack of objective tests, criteria have been developed to reduce the risk of missed diagnosis. The Crain criteria were developed and published in 1997. They only studied patients with alcoholism to keep the sample size homogeneous. After initial development of the requirements using autopsy results from 28 patients, the model was reproduced and validated on an additional 106 patients. 

The Caine criteria for Wernicke encephalopathy require 2 of the following 4 signs:

• Dietary deficiences
• Oculomotor abnormalities 
• Cerebellar dysfunction
• Either an altered mental status or mild memory impairment [12]

Similarly, per the 2010 European Federation of Neurological Societies guidelines, clinical diagnosis of Wernicke encephalopathy is present if the patient has 2 of the following features:

• History of alcohol use disorder with a nutritional deficiency, or any other deficiency state
• Oculomotor abnormalities 
• Equilibrium disorders
• Either an altered mental status or mild memory impairment [3]

Evaluation

Evaluation should include a thorough patient history focused on nutrition, along with a complete physical examination, a comprehensive laboratory workup, and appropriate imaging. There are no specific, timely laboratory tests for diagnosing Wernicke encephalopathy, as it is a clinical diagnosis based on the aforementioned classic signs and symptoms. The diagnosis can be confirmed by measuring blood thiamine concentration or red blood cell transketolase activity. Still, these tests have a prolonged turnaround time and should not be relied upon to initiate treatment. In addition, erythrocyte transketolase levels can be used to detect thiamine deficiency. Levels of lactate and pyruvate are often measured since thiamine is a cofactor for the pyruvate dehydrogenase enzyme. Results of these specialized studies are not readily available and would not be useful in the immediate diagnosis or treatment. 

A complete blood count and a comprehensive metabolic panel can be completed to exclude other causes of central nervous system abnormalities. Moreover, routine brain imaging cannot exclude Wernicke encephalopathy and is therefore not particularly informative beyond identifying any alternative cause of the patient's symptoms. As discussed, the Caine criteria were established in 1997, which is now 85% sensitive if patients have 2 or more of the classic features that include: ataxia, confusion, and ophthalmoplegia.[1][13][14] 

CT imaging may demonstrate reduced attenuation in the periaqueductal gray matter; however, findings are often normal during the acute phase of Wernicke encephalopathy. MRI is considered the best method for confirming the diagnosis of this condition, although typical patterns are observed in only 58% of patients. MRI may reveal hyperintense signaling in the periventricular thalamus, mammillary bodies, and the periaqueductal grey matter. These findings are bilateral and symmetrical. MRI has low sensitivity (53%) but high specificity (93%) for the diagnosis of Wernicke encephalopathy.[3][6]

Treatment / Management

Wernicke encephalopathy is a medical emergency and is considered a treatable and reversible condition requiring immediate emergent attention. Evidence remains heterogeneous, and systematic reviews note a lack of high-quality randomized controlled trials that precisely define the optimal dose or duration of thiamine supplementation. Parenteral administration of thiamine is most effective and allows rapid administration; intravenous administration is preferred over intramuscular. Oral dosing is not reliable and not recommended. Traditional dosing recommendations are 100 mg/day, but this is likely insufficient, especially in patients with alcohol use disorder. Because the plasma half-life of thiamine is only 96 minutes, administration 2 to 3 times daily is preferable to once-daily administration.[15]

Widely used, guideline-consistent options include:

• Royal College and United Kingdom guidelines: Thiamine 500 mg intravenously every eight hours for three days, then 250 mg intravenously or intramuscularly once daily until improvement plateaus, often a further 3 to 5 days. Afterward, administer oral thiamine, 50 to 100 mg daily.[16]
• European Federation of Neurological Societies: Thiamine, 200 mg intravenously, every 8 hours until no further improvement is observed.[17]

There is some evidence that thiamine treatment can improve the confusional state and quickly resolve ataxia, ophthalmoplegia, and nystagmus. Thiamine is generally administered before or concurrently with glucose solutions because glucose oxidation can deplete thiamine, thereby exacerbating the neurological symptoms of Wernicke encephalopathy. Patients with magnesium deficiency should also be treated with magnesium supplementation, as hypomagnesiumemia can reduce recovery from Wernicke encephalopathy, especially in patients with alcoholism.[18][19][20] Patients must be admitted to the inpatient setting to ensure they receive intravenous thiamine and magnesium. 

Thiamine is well tolerated across routes of administration and doses, with few adverse effects. Rarely, anaphylactic allergic reactions can occur, and this is seen mostly with multiple doses of intravenous thiamine. This vitamin is recommended for intravenous administration as thiamine diluted in 100 mL of normal saline or 5% glucose, infused over 30 minutes.[6] 

High-Risk Groups

The American Society for Metabolic and Bariatric Surgery provides recommendations for prevention, diagnosis, and treatment in this group. Importantly, maintain a low threshold for administering intravenous thiamine to patients with vomiting, poor intake, or rapid weight loss, and ensure that lifelong micronutrient supplementation pathways are in place.[21] There are 2 prophylaxis regimens: thiamine 100 mg orally 3 times daily for low-risk individuals, and thiamine 250 mg intramuscular daily for 3 to 5 days in all high-risk individuals.[15][6] 

Hospitals should maintain prophylactic thiamine pathways for patients at risk, including those with alcohol misuse, malnutrition, perioperative stress, or those receiving intravenous glucose or parenteral nutrition. Dietitians should be involved early after surgery and during critical illness. Routine supplementation in alcohol use disorder and vigilant follow-up after bariatric procedures reduce the chance of missed deficiency, although the effect size is difficult to measure precisely.

Differential Diagnosis

Differential diagnoses include:

• Hepatic encephalopathy
• Stroke/cerebral vascular accident 
• Alcohol withdrawal syndrome
• Delirium tremens
• Chronic hypoxia
• Closed head injury
• Normal pressure hydrocephalus 
• Postictal state 
• Psychosis/mental health crisis   

Other conditions that can have bilateral symmetric lesions in the medial thalami on MRI include: 

• Deep cerebral venous thrombosis
• Paramedial thalamic syndrome
• Top-of-the-basilar syndrome
• Japanese encephalitis
• Atypical Creutzfeldt-Jakob disease
• Influenza A virus infection 

Metronidazole-induced encephalopathy can have symmetric signal-intensity alterations in the dentate nuclei, cranial nerve nuclei, red nuclei, and splenium.[3] 

Prognosis

Wernike encephalopathy is a severe, life-threatening disorder with a high degree of morbidity and mortality. Although thiamine treatment can improve symptoms, particularly when initiated promptly, complete resolution is often not achieved. The response to treatment is predictable and constant for ocular symptoms, and they usually respond very well. Improvement in ptosis and gaze palsies can occur in days to weeks. If there is no improvement in the patient's ocular symptoms with appropriate thiamine replacement, the clinician should consider alternative diagnoses.

Improvement in gait ataxia is often delayed, and most patients are left with residual gait disturbances. Although there can be an improvement in the patient's mental status with treatment, residual neurologic deficits are common. While milder symptoms such as confusion, drowsiness, and apathy respond well, memory and learning difficulties have poor recovery. Many patients will then experience permanent neurological deficits and Korsakoff amnesia.[15] Korsokoft syndrome can complicate these cases in 85% of patients, and can lead to death in 20%.[22] 

Complications

The most concerning complication of Wernick encephalopathy is Korsakoff syndrome, with permanent amnesia. Other potential complications include hepatic encephalopathy, osmotic demyelination syndrome (previously known as central pontine myelinolysis), status epileptics, and posterior reversible encephalopathy syndrome.[3]

Consultations

An interdisciplinary approach to the management of Wernicke encephalopathy is essential. Specialist consultation with toxicologists, intensivists, neurologists, and the psychiatric team can improve outcomes. 

Deterrence and Patient Education

Early education prevents missed cases and reduces long-term disability. Patients and caregivers should be educated about the fact that Wernicke encephalopathy is an emergency that requires immediate treatment with intravenous thiamine.

Core messages for patients and families

• Recognize the warning signs: new confusion, unsteadiness of gait, or changes in eye movement require urgent care.
• Do not wait for imaging or laboratory results before starting thiamine if a clinician suspects this condition.
• Alcohol use disorder increases risk; offer referral to addiction services and nutrition support.
• Take prescribed thiamine exactly as directed and do not stop when symptoms improve.
• Maintain magnesium and other vitamins within the recommended range as advised by the care team.

Hospital and clinic prevention

• Use standing orders for thiamine in patients with malnutrition, alcohol misuse, vomiting, or poor intake.
• Administer dextrose for low blood sugar, with concomitant thiamine.
• Involve nutrition and pharmacy early to guide dosing and to prevent drug nutrient conflicts.

Discharge planning

• Provide a clear written plan in the patient's language; include thiamine dose, timing, and expected duration.
• Use teach-back to confirm understanding; schedule follow-up to assess adherence and nutrition.

Special settings

• After bariatric surgery, encourage lifelong vitamin use and seeking prompt care for vomiting or rapid weight loss.
• In pregnancy complicated by hyperemesis, emphasize early supplementation with thiamine and prenatal vitamins.
• In dialysis or cancer care, review vitamin needs at each visit.

Team communication

• Develop a simple checklist applicable to emergency, inpatient, surgical, and primary care.
• Track time to first thiamine and adherence to the pathway to support quality improvement.

Pearls and Other Issues

Current guidelines on managing Werneke encephalopathy include the following:

• Clinical diagnosis of Werneke encephalopathy should be considered in those experiencing alcoholism if the individual has a dietary deficiency, cerebellar dysfunction, ocular signs, and/or altered mental status.
• Total thiamine levels in the blood should be measured before treatment; however, treatment should not be delayed if results are not immediately available. 
• MRI can be used to support the clinical diagnosis of Werneke encephalopathy, but should not be relied upon for confirmation. 
• Thiamine should be given intravenously. 
• After bariatric surgery, follow thiamine levels and supplement with thiamine for at least 6 months.

Enhancing Healthcare Team Outcomes

The management of Wernicke encephalopathy is complex and requires a team approach. Because the disorder can present with various manifestations, the condition is best managed by a neurologist, a toxicologist, and an intensivist. Other specialists may be required depending on the extent of organ involvement. The role of the nurse, dietitian, social worker, and pharmacist cannot be overemphasized as these patients are sick, frail, and malnourished.

A dietary consultation should be obtained to assess caloric needs and determine how to provide food and thiamine. Because many patients with Wernicke encephalopathy require additional outpatient care, it is also essential to involve internal medicine and connect the patient with a local clinic or practice. The treating team should encourage abstinence from alcohol as well and assist in enrolling the patient in additional services, such as inpatient or outpatient detox and rehabilitation.

Because thiamine is the cornerstone of therapy, compliance is vital. At the same time, the electrolyte deficiencies should be corrected. Finally, the family should be informed about the prognosis for these individuals and prepare for long-term care if the patient develops Korsakoff syndrome. Close communication among team members is vital to ensure that the patient is receiving the current standard of care. The ultimate goal is to improve the quality of life and lessen the burden on the family.[23][24]

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Karakonstantis S, Galani D, Korela D, Maragou S, Arna D, Basta M. Missing the early signs of thiamine deficiency. A case associated with a liquid-only diet. Nutr Neurosci. 2020 May;23(5):384-386. [PubMed: 30092713]

2.

Oudman E, Wijnia JW, Oey MJ, van Dam MJ, Postma A. Preventing Wernicke's encephalopathy in anorexia nervosa: A systematic review. Psychiatry Clin Neurosci. 2018 Oct;72(10):774-779. [PubMed: 29984541]

3.

Ota Y, Capizzano AA, Moritani T, Naganawa S, Kurokawa R, Srinivasan A. Comprehensive review of Wernicke encephalopathy: pathophysiology, clinical symptoms and imaging findings. Jpn J Radiol. 2020 Sep;38(9):809-820. [PubMed: 32390125]

4.

Shabbir S, Tong O, Gluck L, Robbins M. Convergence Spasm in Wernicke Encephalopathy. Neurohospitalist. 2018 Jan;8(1):NP1-NP2. [PMC free article: PMC5734497] [PubMed: 29276567]

5.

Tang L, Alsulaim HA, Canner JK, Prokopowicz GP, Steele KE. Prevalence and predictors of postoperative thiamine deficiency after vertical sleeve gastrectomy. Surg Obes Relat Dis. 2018 Jul;14(7):943-950. [PubMed: 29803410]

6.

Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007 May;6(5):442-55. [PubMed: 17434099]

7.

Li S, Xing C. Wernicke encephalopathy: a mini review of the clinical spectrum, atypical manifestations, and diagnostic challenges. Front Neurol. 2025;16:1566366. [PMC free article: PMC12307376] [PubMed: 40740851]

8.

Arts NJ, Walvoort SJ, Kessels RP. Korsakoff's syndrome: a critical review. Neuropsychiatr Dis Treat. 2017;13:2875-2890. [PMC free article: PMC5708199] [PubMed: 29225466]

9.

Liu D, Ke Z, Luo J. Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy. Mol Neurobiol. 2017 Sep;54(7):5440-5448. [PMC free article: PMC5337452] [PubMed: 27596507]

10.

Kim WJ, Kim MM. Wernicke's Encephalopathy Presenting with Bilateral Complete Horizontal and Downward Gaze Palsy in a Malnourished Patient. Korean J Ophthalmol. 2017 Aug;31(4):372-374. [PMC free article: PMC5540996] [PubMed: 28682019]

11.

Sukop PH, Kessler FH, Valerio AG, Escobar M, Castro M, Diemen LV. Wernicke's encephalopathy in crack-cocaine addiction. Med Hypotheses. 2016 Apr;89:68-71. [PubMed: 26968913]

12.

Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):51-60. [PMC free article: PMC486695] [PubMed: 9010400]

13.

Jan K. Wernicke encephalopathy: (MRI) picture worth a thousand words. Oxf Med Case Reports. 2018 May;2018(5):omy013. [PMC free article: PMC5965079] [PubMed: 29868178]

14.

Diekfuss JA, De Larwelle J, McFadden SH. Diagnosis makes a difference: Perceptions of older persons with dementia symptoms. Exp Aging Res. 2018 Mar-Apr;44(2):148-161. [PubMed: 29400641]

15.

Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. Wernicke Encephalopathy-Clinical Pearls. Mayo Clin Proc. 2019 Jun;94(6):1065-1072. [PubMed: 31171116]

16.

Alim U, Bates D, Langevin A, Werry D, Dersch-Mills D, Herman RJ, Mintz M, Ghosh S. Thiamine Prescribing Practices for Adult Patients Admitted to an Internal Medicine Service. Can J Hosp Pharm. 2017 May-Jun;70(3):179-187. [PMC free article: PMC5491193] [PubMed: 28680171]

17.

Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA., EFNS. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010 Dec;17(12):1408-18. [PubMed: 20642790]

18.

Onishi H, Ishida M, Uchida N, Shintani D, Nishikawa T, Hasegawa K, Fujiwara K, Akechi T. Subclinical thiamine deficiency identified by preoperative evaluation in an ovarian cancer patient: Diagnosis and the need for preoperative thiamine measurement. Palliat Support Care. 2019 Oct;17(5):609-610. [PubMed: 30168403]

19.

Johnson JM, Fox V. Beyond Thiamine: Treatment for Cognitive Impairment in Korsakoff's Syndrome. Psychosomatics. 2018 Jul-Aug;59(4):311-317. [PubMed: 29751937]

20.

Oudman E, Wijnia JW, van Dam M, Biter LU, Postma A. Preventing Wernicke Encephalopathy After Bariatric Surgery. Obes Surg. 2018 Jul;28(7):2060-2068. [PMC free article: PMC6018594] [PubMed: 29693218]

21.

Patterson E, Kurian M, Sann N, Dan A, Lovato C, Hinojosa M, Sockalingam S, Craggs-Dino L, Samakar K, Duncan K., ASMBS Wernicke's Task Force. ASMBS literature review & clinical guidelines on prevention, diagnosis, and treatment of Wernicke's encephalopathy and Wernicke-Korsakoff syndrome. Surg Obes Relat Dis. 2025 Jul;21(7):707-718. [PubMed: 40345894]

22.

Habas E, Farfar K, Errayes N, Rayani A, Elzouki AN. Wernicke Encephalopathy: An Updated Narrative Review. Saudi J Med Med Sci. 2023 Jul-Sep;11(3):193-200. [PMC free article: PMC10393093] [PubMed: 37533659]

23.

McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):854-62. [PubMed: 17986499]

24.

Donnelly A. Wernicke-Korsakoff syndrome: recognition and treatment. Nurs Stand. 2017 Mar 29;31(31):46-53. [PubMed: 28351256]

Disclosure: Jagkirat Singh declares no relevant financial relationships with ineligible companies.

Disclosure: Angela Regina declares no relevant financial relationships with ineligible companies.